Introduction
In the past 2-3 years there have been considerable advances in our understanding of thc neuroendocrine processes controlling pituitary function (Clarke, 1987) and the nature of steroidal and non-steroidal feedback regulation, particularly by the gonadal peptide. inhibin (Findlay, 1986) . These advances offer new insights into the regulation of gonadotrophin secretion and gonadal function, and could have a considerable commercial impact in animal industry. In this review, we summanze these advances with respect to the control of FSH secretion in sheep and cattle.
Patterns of FSH secretion
The main characteristics of the patterns of FSH concentration in peripheral plasma of sheep (L'Hermite el al., 1972; Salamonsen et al., 1973) and cows (Walters & Schallenberger, 1984; Quirk & Fortune, 1986) arc (a) relatively low levels, compared to the luteal phase, of FSH during the 1-2 days before the preovulatory surge of gonadotrophins, i.e. when LH and oestradiol secretion are increasing (Baird & McNeilly, 1981) , (b) a peak of FSH secretion coincident with the preovulatory surge of LH, both of which are induced by oestradiol (Jonas et al., 1973; Kesner & Convey, 1982) , (c) a second surge of FSH commencing 18-24 h after onset of the preovulatory release, reaching peak concentrations just after ovulation when LH and oestradiol concentrations are both low (Baird & McNeilly, 1981) and (d) fluctuating concentrations of FSH during the remainder of the cycle. It has been estimated that the major sources of variation in peripheral concentrations of FSH during the oestrous cycle of the ewe are attributable to animals (75%) and time of sampling (16% between days and 9% between hours) (Findlay & Cumming, 1976) . Unlike LH, FSH secretion in sheep is not pulsatile (see Clarke et al.. 1986 ), whereas there is evidence of pulsatility in cattle (Walters & Schallenberger, 1984) .
Measurements of metabolic clearance (MCR) of FSH (Akbar et al., 1974; Findlay & Cumming, 1976) support the notion that the changes in peripheral concentrations of FSFI are due to changes in secretion by the pituitary gland and not removal of hormone from blood.
In addition to the cyclic changes there are other factors known to influence FSH secretion. For example, in sheep the concentrations of FSH have been related to breed (Lahlou-Kassi al., 1984; Bindon et aL, I985a, b) , sex (Findlay et al., 1985) , nutrition (Scaramuzzi & Radford. 1983) , season (Findlay & Cumming, 1976; Findlay et al , 1985) and age (Lee et aL, 1976: Bindon et al., 19856) . In all of these instances, and especially during the ovarian cycle, it is apparent that the secretion of FSFI can change independently of LH secretion, indicating that the control systems regulating the two pituitary gonadotrophins are not necessarily the same. There is evidence that the control processes regulating FSH, which are independent of those controlling LH, reside at the level of the hypothalamus and the pituitary gland and in the nature of the feedback influences of the gonads. et al., 1978) .
Hypothalamic control of FSH secretion
-fhe hypothalamic influence on pituitary FSH secretion involves GnRH, which will stimulate secretion of both LH and FSH in vivo in sheep (Jonas et al., 1973) and cattle (Kesner & Convey, 1982) .
The existence of a specific FSH-releasing hormone has been postulated (Bowers et al.. 1973 
Gonadal control of FSH secretion
It is well established that the gonads can influence the secretion of both FSH and LH due to the inhibitory effects of gonadal steroids (Goodman & Karsch, 1981) . In the female, there is also a positive feedback effect of oestradiol on FSH and LH secretion (Jonas el al., 1973; Kesner & Convey. 1982) which is responsible for the preovulatory surge of gonadotrophins during the ovarian cycle. The feedback control of gonadotrophin secretion by steroids can be manifested at both the hypothalamic and pituitary level. Clarke (1987) has defined two types of negative feedback effect of oestrogen in sheep. in addition to the positive effect mentioned above. The short-term negative feedback effect is seen when ovariectomized ewes are treated with oestradiol (Clarke et al., 1982) . Both LH and FSH concentrations fall in peripheral plasma. The effects of LH are apparent within 2 h, but shortly thereafter the secretion is increased to give a surge in LH. In contrast, the decrease in FSH is not observed until 4-5 h after oestrogen injection and continues for up to 24 h. The evidence available (Clarke, 1987) supports the view that this short-term negative effect is the result of a pituitary action of oestrogen and does not involve effects on GnRH secretion.
The long-term negative feedback effects are seen when oestradiol alone holds LH concentrations below those of untreated ovariectomized ewes (Diekman & Malven. 1973) . Oestradiol in combination with progesterone in the correct sequence and doses can result in changes in LH concentration in ovariectomized ewes which mimic those of intact. cyclic animals (Goodman et al., 1981) , and the effects of these steroids are exerted via GnRH secretion (Clarke, 1987) .
The situation with FSH is different. Although oestradiol has a long-term negative influence on FSH secretion, none of the steroid replacements maintained FSH concentrations in the physiological range, although some suppression was evident (Goodman et al., 1981) Furthermore, the rise in oestradiol in the preov ula tory period could not account for the low basal FSH concentrations observed in that period (Goodman et al., 1981) , and an effect of steroids could not account for the selective increase in FSH on Day 1 of the cycle. These results supported the hypothesis that an ovarian hormone other than oestradiol and progesterone inhibits FSH secretion, and that this putative hormone is selective for FSH because the secretion of LH can be accounted for by the combination of oestradiol and progesterone in the female The remainder of this review will consider the evidence that the hormone is the gonadal peptide, inhibin.
Control of FSH secretion by inhibin
Inhibin is defined as a gonadal peptide which selectively suppresses the secretion of FSH. Although inhi bin was discovered as a testicular hormone (see Baker (if al., 1982) , it is also present in the ovary (Baker et al., 1982) particularly in follicular fluid (cow: de Jong & Sharpe, 1976; sheep: Tsonis et al.. 1983 ) which has proved a useful source of inhibin activity for experimentation and purification of the hormone. In males, the activity is found in testicular extracts. rete testis fluid, testicular lymph, seminal plasma and in media from cultures of seminiferous tubules and Sertoli cells (Baker el al., 1982) .
The gonadal fluids and extracts containing inhibin activity have been shown to suppress FSH secretion selectively or preferentially in in-vivo and in-vitro test systems (Baker el al., 1982) . FSFI secretion is suppressed by follicular fluid in ovariectomized (Cummins et al., 1983; Findlay et al.. 1985) and intact (Miller et al., 1982) ewes and castrated males (Findlay er al., 1985) , and by Fete testis Iluid in castrated rams (Hudson et al.. 1979) . Bovine follicular fluid will also selectively suppress the plasma concentrations of FSH in cows (Quirk & Fortune, 1986) . In many of these experiments the effects of inhibin activity in vivo have been dose dependent. Unlike oestradiol negative feedback (Goodman & Karsch. 1981) , there does not appear to be an influence of season on the ability of inhibin to suppress FSH secretion (Findlay el al., 1985) . Both ovine follicular fluid (Tsonis et aL, 1983 (Tsonis et aL, , 1986 and rete testis fluid (Hudson el al., 1979; Tsonis et al., 1986) selectively suppress FSH in rat and sheep pituitary cell assays in vitro The in-vivo post-castration suppression of FSH and the in-vitro pituitary cell culture assays are accepted as being the most specific and reliable assays at present available for inhibin (Hudson et aL, 1979; Baker et al., 1982) .
Lvolation and eharacteriattion of inhibin
Inhibin has been a difficult molecule to isolate and purify and so there has been considerable confusion about its physico-chernical characteristics (see de Jong & Robertson, 1985; Findlay, 1986) . This is due to a combination of factors including the source of inhibin, ill-defined bioassay systems, the lack of standard reference preparations, the nature of the molecule itself and the inability of standard purification procedures to separate inhibin. Recent reports of the purification of inhibin over 3000-fold from cow (Robertson et al.. 1985 , 1986 : Fukuda et al., 1986 . sheep (Leversha et al., 1986) and pig (Miyamoto et al.. 1985; Ling el al.. 1985; Rivier et al., 1985) follicular fluid have resulted in a convergence of opinion about the physico-chemical properties of inhibin in the ovary. Inhibin has an apparent molecular weight ranging from 31 000 to 100 000 of which the forms of Mr 31-32 000 and 55 000-65 000 have been more extensively purified. Two forms of bovine inhibin have been purified: one is a protein of M, 58 000 which dissociated into subunits of 43 000 (a) and 15 000 (0) (Robertson et al.. 1985) , and the other is a protein of M, 31 000 consisting of a (14, 20 000) and [3(M1 13-15 000) subunits (Robertson et al.. 1986; Fukuda et al., 1986) . It was shown that the form of Mr 31 000 could be generated by including an acid pH precipitation step in the purification procedure for cow: follicular fluid (Robertson et al., 1986) , suggesting that cleavage of the u-subunit resulted in the smaller form. This was confirmed by cloning and sequence analysis of cDNA species coding for the 2 subunits of bovine inhihin (Forage et al., 1986) ; the a subunit contained a cleavage site at residues 165, 166 which would produce the form of M r 20 000 (ac fragment) from that of M, 43 000 (Fig. I) .
Ovine inhibin has been isolated as forms of Mr 67 000 and 32 000, the latter being purified to homogeneity and consisting of a (M, 20-21 000) and 0 (M, 16 000) subunits (Leversha et al., 1986) Similarly, porcine inhibin of M, 32 000 has been purified and consists of a (M, 20 000) and 13(M, 13 000) subunits (Miyamoto et aL, 1985 : Ling el al., 1985 Rivier ei al., 1985) . Ling et al. (1985) reported 2 forms of porcine inhibin (A and B) based on heterogeneity of the amino acid sequence in the 13subunit, which was subsequently confirmed by cloning and sequence analysis of cDNA (Mason et al , 1985) . This heterogeneity has not been observed with bovine or ovine inhihin. In all species examined, potential glycosylation sites appear to be confined to the a-subunit.
The results suggest that at least 3 genes are present in the ovary which code for the subunits of Forage et al., 1986.) inhi bin, each of which share considerable sequence homology, indicative of a common ancestral gene (Mason et al., 1985) . Cloning and sequencing of cDNA coding for human inhibin (Mason et al., 1986) have confirmed the similarity of the genes coding for inhibin amongst different species and underlined the extensive homology of the subunits between species. Interestingly, it is the 13-subunit of inhibin which shares sequence homology with transforming growth factor-13 (Derynck et al., 1985) and M iillerian Inhibiting substance (Cate et al., 1986) , raising the possibility that these are members of a family of proteins which influence cell function in similar manner. It is the P-subunits of inhibin which form homo- (Vale et al., 1986) and hetero-(ling et al., 1986 ) dimers and are found in pig follicular fluid which have potent FSH stimulating activity in vitro. Although these p-dimers may be secreted by the gonad and act on the pituitary (see above), they may also have a local, intragonadal action. The fact that TGF-f3 enhanced and porcine inhibin of Afr 32 000 antagonized the ability of FSH to stimulate secretion of oestradiol by rat granulosa cells in vitro (Ying et aL, 1986b) underlines the possibility of a paracrine autocrine action of these inhibinrela ted polypeptides. Published data on purification of inhibin from the male is not as advanced as that from ovarian follicular sources (see de Jong & Robertson, 1985; Findlay, 1986 ). Sairam et al. (1981 reported an inhibin of M, 18 000 in bovine seminal plasma to be purified 500-fold. Activity of an M, 20 000 protein has been isolated from ovine testicular extracts and claimed to be purified 770-fold (Moudgal et al., 1985) , but the assay used to monitor activity has been questioned (Hudson et aL, 1979) .
The availability of pure bovine inhi bin has allowed development of a rachoimmunoassay which is applicable to cattle and humans (McLachlan et al., 1986) and should ensure more rapid progress in our knowledge of the physico-chemical characteristics and physiology of inhibin. However, in view of the existence of dimers based on the 13-subunits of inhibin (Vale et al., 1986; Ling et al., 1986) and their homology with TGF-P and Mfillerian inhibiting substance (see above), it will be important to establish the specificity of the antibodies raised against inhibin. The antiserum to bovine inhibin (M, 58 000) cross-reacts with the form of Mr 32 000 but not with the subunits (McLachlan et al., 1986) , suggesting that it is directed against conformational sites on the intact molecule and is therefore specific for inhibin.
Production and transport of inhibin
Inhibin activity is produced by the granulosa cells of the ovary (cow: Henderson & Franchimont, 1981) and the Sertoli cells of the testis (see Baker et aL, 1982) . The inhibin content, and to a lesser extent the concentration, increases with follicular size and decreases with atresia of large follicles in sheep (Tsonis et al., 1983) and cows (Henderson et al., 1984) . Treatment of hypophysectomized ewes with PMSG increased the inhibin content of the ovary (Cahill et al., 1985) . However, treatment of bovine granulosa with gonadotrophin in vitro did not significantly alter inhibin production, although micromolar doses of androgen did cause a stimulation (Henderson & Franchimont, 1983) . The route by which inhibin leaves the testis to reach the peripheral circulation is unclear (see Baker et al., 1982) . It might pass through the seminiferous tubules and rete testis and be absorbed into the circulation at the head of the epididymis. It is also likely to enter the testicular capillaries from the lymph spaces surrounding the seminiferous tubules. Baker et aL (1982) have estimated that the daily output of inhibin in testicular lymph is at least equal to that in rete testis fluid of the ram and sufficient to maintain a tonic inhibition of FSH. They were unable to measure inhibin activity in testicular vein blood of rams, using the rat pituitary cell bioassay.
Using a similar bioassay, Findlay et aL (1986) measured inhibin in ovarian lymph of PMSG-treated ewes, but could not detect it in ovarian or jugular venous plasma. Destruction of visible follicles by electrocautery was followed by a rapid decline in secretion of in hibin in ovarian lymph. Findlay et al. (1986) concluded that inhibin could reach the peripheral circulation by the ovarian lymphatic system, particularly in the luteal phase when lymph flow rates are high. However, because venous outflow from the gonads is many times greater than lymph flow, relatively small concentrations of inhibin in venous plasma can make a major contribution to peripheral concentrations, Tsonis et al. (1986) have developed a more sensitive in-vitro assay using sheep pituitary cells which detected inhibin activity in ovarian venous plasma of a control and an FSH-treated ewe, and in peripheral plasma of the FSH-treated ewe. They showed higher concentrations of inhibin in the ovarian vein than in peripheral blood, particularly after treatment with FSH.
The half-lift of ovine inhibin activity in peripheral blood of ovariectomized ewes was calculated to be around 45 50 min (Findlay et al., 1986) . In intact ewes. Tsonis ci al. (1986) observed 2 half-life components of 18-24 and 50 60 min after injection of ovine follicular fluid. In both studies, the inhibin concentrations in plasma remained elevated after injection for up to 30 min before exponentially decaying, and in the intact ewes duration of the plateau was dose-dependent. This may reflect equilibration of inhibin to a carrier protein, dissociation of bound or polymeric forms. or saturation of a cleavage enzyme necessary for clearance or release from a polymeric form_ It could also reflect the presence of the FSH-stimulating p-dimers (Vale et al.. 1986 : Ling et al , 1986 in ovine follicular fluid which would reduce the 'apparent' inhibitory effect of inhibin in the in-vitro bioassay until such time as they are cleared from the circulation. We suggest that the li-dimers would have a more rapid clearance than inhibin because of the lack of glycosylation sites on the ri-subunits (see above).
Act ion of inhibin
That inhibin has a pituitary site of action is amply demonstrated by the effect of extracts and Iluids containing inhibin activity (Baker ci al., 1982) and pure inhibins from cows, pigs and sheep (Robertson et al., 1985 . 1986 : Miyamoto et al.. 1985 : Rivier et al , 1985 , Ling et al., 1985 : Fukuda et al_ 1986 : Leversha et al., 1986 on FSH release by pituitary cell cultures in vitro. The effect of pure inhibin (forms of M r -58 000 and -32 000) at lower doses is specific for FSH release in that there were no significant changes in LH or prolactin release in vitro. At higher doses, pure inhibin will suppress LH in vitro (Farnworth et al.. 1986) . A direct pituitary site of action was recently demonstrated in vivo (Clarke et al., 1986) when it was shown that treatment with ovine follicular fluid caused a 95% reduction in plasma FSH concentrations in ovariectomized ewes that had been subjected to hypothalamo-pituitary disconnection and in which gonadotrophin secretion had been reinstated with 250 ng pulses of CinRH every 2 h.
Whether or not inhibin has a hypothalamic action to limit secretion of GnRH is less certain. Intrahypothalamic and intraventricular injections of inhibin activity suppressed plasma FSH concentrations in laboratory rodents (see Clarke et al., 1986 , for references) but the mechanisms for these effects were not clear.
High doses of inhibin activity are known to inhibit both FSH and LH release induced by endogenous GnR1-1 in ovariectomized ewes (Findlay et al., 1985) . Since LH pulses reflect GnRH secretion (Clarke & Cummins. 1982) it is possible to assess, indirectly, the effects of high doses of inhibin on hypothalamic function by examining LH pulse frequency in ovariectomized ewes. Similar studies in intact ewes (McNeilly, 1984; Wallace & McNeilly, 1985) are difficult to interpret because cffconfounding effects of oestrogens on GnRI-1 pulse frequency (Clarke, 1987) . Large doses of ovine follicular fluid given to ovariectomized ewes causes a significant reduction in plasma FSH and LH concentration, the latter probably due to a reduction in LH pulse amplitude in 3/4 animals, but no change in LH pulse frequency (Clarke et al., 1986) . The ability of follicular fluid containing inhibin activity to reduce LH pulse amplitude by a direct action on the pituitary was confirmed in experiments using ovariectonnized ewes with hypothalamo-pituitary disconnection (Clarke et al., 1986) . Overall, these experiments suggest that inhibin does not act on hypothalamic or extrahypothalamic centres that determine GnRH pulse frequency. The major effect of inhibin is to This phenomenon is unlikely to be due to an immune response to bovine follicular fluid, given the relatively short duration of treatment (Wallace & McNeilly, 1985) . It may be due to a long-term reduction in ovarian production of inhibin and oestradiol allowing a partial increase in pituitary FSH secretion (Henderson et al., 1986) . Or there could be a refractory (down-regulation?) effect at the pituitary level.
Inhibin mid fecundity
FSH controls gamete production in the gonads and therefore manipulation of FSH secretion through an influence on inhibin production and action offers a means of improving fecundity in domestic animals. One way to achieve this would be to select animals with low inhibin production. The highly fecund Booroola Merino ewe has a lower ovarian content of inhibin than control Merinos (Cummins et al., 1983) . This would lead to higher FSH secretion and the consequent effects on the gonads and suggests variation in the inhibin gene may be the basis of the increased fecundity in the Booroolas (Bindon et al., 1985b) . D'man sheep are also highly fecund and have high circulatory FSH concentrations (Lahlou-Kassi et al., 1984) but their inhibin levels have not been reported.
A second method to increase fecundity would be to neutralize circulating inhibin by active or passive immunization. Cummins et al. (1986) observed an increase in ovulation rate after immunization of ewes with a fraction of bovine follicular fluid containing inhibin activity. The plasma FSH concentrations in the Immunized animals were increased compared with controls (Al-Obaidi et al., 1987) , and plasma from immunized ewes inhibited the FISH-suppressing activity of bovine follicular fluid administered to ovariectomized ewes (Al-Obaidi et al., 1986) , suggesting that antibodies had been raised against inhibin. Now that inhibin has been purified and the cDNA cloned (see above) it should be possible to repeat these experiments with pure inhibin, its subunits and fragments to assesswhether this is a practical method of improving fecundity.
Finally, it has been observed (Miller et al., 1982; Wallace & McNeilly, 1985; Henderson et al., 1986; Quirk & Fortune, 1986 ) that, 24-36 h after cessation of treatment of intact ewes and cows with follicular fluid, there is a rebound effect on plasma FSH such that concentrations exceed those in control animals. This treatment increased the proportion of multiple ovulating ewes (Wallace & McNeilly, 1985; Henderson et al., 1986) , an effect attributed to the increase in FSH. If similar increases in ovulation rate can be achieved using pure or synthesized inhibin during the late luteal phase of the cycle, this method may also improve fecundity of animals.
Conclusions
The secretion of FSH and LH has been shown to vary independently in physiological and experimental situations, indicating independent regulatory mechanisms for each gonadotrophin. The regulation of FSH can occur at three levels, i.e. hypothalamus and higher brain centres, the pituitary gland and the gonad. At the hypothalamus, specific FSH-releasing hormones have been postulated but never proven conclusively. The demonstration that homo-and heterodinners of the P-chain of inhibin have potent FSH-releasing activities offers new scope in that area. At the pituitary, there is evidence that the gonadotrophs which synthesize and secrete FSH have a much greater capacity to continue that function than those which produce LH. This indicates intra-and intercellular differences in the regulation of LH and FSH and offers an experimental challenge in the area of control of synthesis, processing and packaging of the gonadotrophin subunits. Finally, regulation of FSH occurs at the level of the gonad through production of agents such as inhibin which selectively influence FSH secretion.
Inhibin has now been isolated from follicular fluid of cows, sheep and pigs and purified to homogeneity. The cDNA coding for bovine, porcine and human inhi bin messenger RNA has been cloned and sequenced. Inhibin is a heterodimer in which a larger. glycosylated a-chain (Mr 20 000-43 000) is joined to a smaller p-chain (M, 13-15 000) by disulphide bridges. Pure inhibin is biologically active in vivo and in vitro and radioimmunoassays for measuring inhibin have been developed. Collectively, this should provide an impetus to describe the physiology of inhibin in the next few years.
There arc already some surprises. Inhibin shares amino acid sequence homology with the cell regulator. TGF-13. and with Mullerian inhibiting substance, suggesting that these peptides belong to a gene family whose products have cell regulatory properties at endocrine, paracrine and/or autocrine levels. In the case of inhibin, reassembly of its subunits to form p-dimers can reverse the activity from inhibitory to stimulatory, indicating that the point of assembly of the subunits is a key control point for subsequent biological activity. Manipulation of inhibin and its 11-chain dimers by analogue treatment, immunization or genetic selection and engineering will provide new insights into the control of reproduction and may offer a means of regulating fecundity of domestic animals- 
